Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor

被引:241
|
作者
AbuAmer, Y [1 ]
Ross, FP [1 ]
Edwards, J [1 ]
Teitelbaum, SL [1 ]
机构
[1] WASHINGTON UNIV, SCH MED, DEPT PATHOL, BARNES JEWISH HOSP N, ST LOUIS, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 1997年 / 100卷 / 06期
关键词
bone resorption; periodontitis; tumor necrosis factor receptor; thalidomide; bone marrow macrophages;
D O I
10.1172/JCI119679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic bone infection, as attends periodontitis, is often complicated by severe osteolysis. While LPS is believed to be central to the pathogenesis of the osteolytic lesion, the mechanisms by which this bacteria-derived molecule promotes bone resorption are unknown. We find that LPS induces bone marrow macrophages (BMMs) to express c-src, a protooncogene product that we demonstrate is a specific marker of commitment to the osteoclast phenotype. We next turned to possible soluble mediators of LPS-induced c-src. Of a number of osteoclastogenic cytokines tested, only TNF-alpha mirrors the c-src-enhancing effect of LPS. Suggesting that LPS augmentation of c-src is TNF-mediated, endotoxin sequentially induces BMM expression of TNF, followed by c-src. TNF and c-src expression, by cultured BMMs derived from LPS-injected mice, reflects duration of exposure to circulating endotoxin, intimating that endotoxin's effect in vivo is also mediated by TNF, Consistent with these findings, thalidomide (which antagonizes TNF action) attenuates c-src induction by LPS, An anti-TNF antibody blacks LPS enhancement of c-src mRNA, validating the cytokine's modulating role in vitro, Using BMMs of TNF receptor-deleted mice, we demonstrate that TNF induction of c-src is transmitted through the cytokine's p55, but not p75, receptor. Most importantly, LPS administered to wild-type mice prompts osteoclast precursor differentiation, manifest by profound osteoclastogenesis in marrow cultured ex vivo, and by a profusion of marrow-residing cells expressing the osteoclast marker tartrate resistant acid phosphatase, in vivo, In contrast, LPS does not substantially enhance osteoclast proliferation in mice lacking the p55TNF receptor, confirming that LPS-induced osteoclastogenesis is mediated by TNF in vivo via this receptor, Thus, therapy targeting TNF and/or its p55 receptor presents itself as a means of preventing the osteolysis of chronic bacterial infection.
引用
收藏
页码:1557 / 1565
页数:9
相关论文
共 50 条
  • [1] Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor.
    AbuAmer, Y
    Ross, FP
    Edwards, J
    Teitelbaum, SL
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S355 - S355
  • [2] Tumor necrosis factor-α accelerates osteoclastogenesis via cooperative intracellular signaling of its p55 TNF receptor with RANK.
    Huelsmann, A
    Zhang, Y
    Abu-Amer, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S188 - S188
  • [3] Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
    Schreyer, SA
    Peschon, JJ
    LeBoeuf, RC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) : 26174 - 26178
  • [4] GENERATION OF MICE DEFECTIVE FOR TUMOR-NECROSIS-FACTOR RECEPTOR P55
    PFEFFER, K
    MATSUYAMA, T
    WAKEHAM, A
    KISHIHARA, K
    POTTER, J
    SHAHINIAN, A
    WIEGMANN, K
    KRONKE, M
    MAK, TW
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 128 - 128
  • [5] Endothelin-1 synthesis is stimulated by a tumor necrosis factor α mutant selective for the p55 TNF receptor
    Lees, D
    Corder, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122
  • [6] Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors
    Ruby, J
    Bluethmann, H
    Peschon, JJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09): : 1591 - 1596
  • [7] Osteoporosis and serum soluble tumor necrosis factor receptor p55 in alcoholic cirrhosis
    Gonzalez-Calvin, JL
    Cabellero, FC
    Gallego-Rojo, F
    Fernandez-Perez, R
    Ruiz-Escolano, E
    Martin-Ibanez, JJ
    Romero, P
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 10A - 10A
  • [8] STRUCTURAL REQUIREMENTS FOR INDUCIBLE SHEDDING OF THE P55 TUMOR-NECROSIS-FACTOR RECEPTOR
    BRAKEBUSCH, C
    VARFOLOMEEV, EE
    BATKIN, M
    WALLACH, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (51) : 32488 - 32496
  • [9] Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55
    Tomita, Y
    Yang, XQ
    Ishida, Y
    Nemoto-Sasaki, Y
    Kondo, T
    Oda, M
    Watanabe, G
    Chaldakov, GN
    Fujii, C
    Mukaida, N
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) : 927 - 933
  • [10] CYTOTOXICITY BY TUMOR-NECROSIS-FACTOR IS MEDIATED BY BOTH P55 AND P70 RECEPTORS
    HELLER, RA
    SONG, K
    FAN, N
    CELL, 1993, 73 (02) : 216 - 216